RE: NIH Grant Enables Cochlear Implant Breakthrough

[Guest guest]

Which cochlear company is this?

[Guest guest]

The research is based around devices by Cochlear Ltd., , but I*suppose*

they could apply it to any in the future. That's just a guess, mind ya!

Bob

.....

From: [mailto: ] On Behalf Of

Sent: Friday, January 28, 2011 9:21 PM

Subject: Re: NIH Grant Enables Cochlear Implant Breakthrough

Which cochlear company is this?

[Guest guest]

I wrote to UT Dallas, asking for clarification of the differences in

functionality between the new technology and that of the Remote Assistant in

Cochlear's Nucleus 5 system. The reply:

Mr MacPherson:

Thanks for your inquiry.

Cochlear's Remote Assistant for the Nucleus 5 system does allow you to

select different environments (e.g., music, noise), however it is limited in

that it only allows you the options offered by the manufacturer. Clinicians

or researchers can not expand or change the (canned) settings for different

individuals accommodating perhaps listening settings encountered in

different professions. Our PDA system is more flexible and provides to

researchers the freedom to program it any way they want. It also offers the

possibility of recording challenging real-world situations/environments, and

bringing those to the lab/clinic to analyze. This will allow the

clinicians/researchers to program the device for a better listening

experienced tailored to each individual patient.

Philip C. Loizou, PhD

Professor and Cecil & Ida Green Chair

University of Texas-Dallas

Dept. of Electrical Engineering

…………………………………………………………………………………

 

Press release, University of Texas at Dallas - January 28, 2011

----------

NIH Grant Enables Cochlear Implant Breakthrough

Project Uses Smartphone Interface to Adjust Settings for Noisy Environments

Many cochlear implant users may soon be able to easily modify the settings

on their hearing devices using a smartphone interface, selecting one setting

for a bustling restaurant, another for a hushed library.

Ten health-care and research facilities across the U.S. are slated to

participate in clinical trials of the technology, pending Food and Drug

Administration approval, says Dr. Philip Loizou, director of the Cochlear

Implant Lab at UT Dallas and principal investigator for the $2.5 million

project, which is funded by the National Institutes of Health.

………………

Complete release:  http://tinyurl.com/4caqogk

(Note: Watch the video for best details)